Literature DB >> 24906863

Estimating minimally important differences for two vision-specific quality of life measures.

Brenda W Gillespie1, David C Musch2, Leslie M Niziol3, Nancy K Janz4.   

Abstract

PURPOSE: To estimate minimally important differences (MIDs) for the Visual Activities Questionnaire (VAQ) and the National Eye Institute-Visual Function Questionnaire (NEI-VFQ).
METHODS: A total of 607 subjects with newly-diagnosed open-angle glaucoma (OAG) was enrolled in the Collaborative Initial Glaucoma Treatment Study (CIGTS) and randomized to initial treatment with medications or surgery. Subjects underwent an ophthalmic examination and telephone-administered quality of life (QOL) interview before randomization and every six months thereafter. The VAQ and NEI-VFQ were used to assess participants' perceptions of their visual function. Clinical measures included the mean deviation (MD) from Humphrey 24-2 full threshold visual field (VF) testing, and best-corrected visual acuity (VA) measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. Anchor-based (using MD and VA) and distribution-based methods were used to estimate MIDs.
RESULTS: Anchor-based cross-sectional analyses at 66 months follow-up found a 10-letter increment in better eye VA corresponded to MIDs of 5.2 units for VAQ and 3.8 units for NEI-VFQ total scores. A 3-dB increment in the better eye MD yielded MIDs of 2.6 and 2.3 units for the same two questionnaires. In longitudinal analyses, MIDs for the VAQ were 3.2 units for a 10-letter change of VA and 3.4 units for a 3-dB change in the MD. Distribution-based MIDs were larger.
CONCLUSIONS: A range of MIDs for the VAQ (2.6-6.5 units) and NEI-VFQ (2.3-3.8 units) was found. Although similar in magnitude, MIDs were sensitive to the MID estimation method, the anchor chosen, and differences between questionnaires. (ClinicalTrials.gov number, NCT00000149.). Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  CIGTS; MID; NEI-VFQ; VAQ; glaucoma

Mesh:

Year:  2014        PMID: 24906863      PMCID: PMC4095718          DOI: 10.1167/iovs.13-13683

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  Defining clinically meaningful change in health-related quality of life.

Authors:  Ross D Crosby; Ronette L Kolotkin; G Rhys Williams
Journal:  J Clin Epidemiol       Date:  2003-05       Impact factor: 6.437

2.  Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Authors:  Kevin D Frick; Lea T Drye; John H Kempen; James P Dunn; Gary N Holland; Paul Latkany; Narsing A Rao; H Nida Sen; Elizabeth A Sugar; Jennifer E Thorne; Robert C Wang; Janet T Holbrook
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

3.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

4.  Quality of life in newly diagnosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study.

Authors:  N K Janz; P A Wren; P R Lichter; D C Musch; B W Gillespie; K E Guire
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

5.  Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.

Authors:  P R Lichter; D C Musch; B W Gillespie; K E Guire; N K Janz; P A Wren; R P Mills
Journal:  Ophthalmology       Date:  2001-11       Impact factor: 12.079

6.  Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes.

Authors:  Michael Cusick; John Paul SanGiovanni; Emily Y Chew; Karl G Csaky; Katherine Hall-Shimel; George F Reed; Rafael C Caruso; Frederick L Ferris
Journal:  Am J Ophthalmol       Date:  2005-06       Impact factor: 5.258

7.  A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale.

Authors:  David T Eton; David Cella; Kathleen J Yost; Susan E Yount; Amy H Peterman; Donna S Neuberg; George W Sledge; William C Wood
Journal:  J Clin Epidemiol       Date:  2004-09       Impact factor: 6.437

Review 8.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

9.  Evaluating clinical change and visual function concerns in drivers and nondrivers with glaucoma.

Authors:  Nancy K Janz; David C Musch; Brenda W Gillespie; Patricia A Wren; Leslie M Niziol
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

10.  Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.

Authors:  Ivan J Suñer; Gregg T Kokame; Elaine Yu; James Ward; Chantal Dolan; Neil M Bressler
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-28       Impact factor: 4.799

View more
  5 in total

1.  Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma.

Authors:  Dana M Blumberg; Carlos Gustavo De Moraes; Alisa J Prager; Qi Yu; Lama Al-Aswad; George A Cioffi; Jeffrey M Liebmann; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

2.  Seeing the patient's perspective: a guide to patient-reported outcome measures and minimal important differences in ophthalmic research.

Authors:  Anila Qasim; Tahira Devji; Mark R Phillips; Charles C Wykoff; Peter K Kaiser; Lehana Thabane; Mohit Bhandari; Varun Chaudhary
Journal:  Eye (Lond)       Date:  2022-02-23       Impact factor: 4.456

3.  Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS).

Authors:  Anthony J King; Jemma Hudson; Gordon Fernie; Ashleigh Kernohan; Augusto Azuara-Blanco; Jennifer Burr; Tara Homer; Hosein Shabaninejad; John M Sparrow; David Garway-Heath; Keith Barton; John Norrie; Alison McDonald; Luke Vale; Graeme MacLennan
Journal:  BMJ       Date:  2021-05-12

4.  Quality of Life of Patients with Glaucoma in Slovakia.

Authors:  Ľudmila Majerníková; Anna Hudáková; Andrea Obročníková; Beáta Grešš Halász; Mária Kaščáková
Journal:  Int J Environ Res Public Health       Date:  2021-01-09       Impact factor: 3.390

5.  Vision Health-Related Quality of Life in Chinese Glaucoma Patients.

Authors:  Lei Zuo; Haidong Zou; Jianhong Zhang; Xinfeng Fei; Xun Xu
Journal:  J Ophthalmol       Date:  2015-10-07       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.